{"id":101166,"date":"2006-11-30T08:32:39","date_gmt":"2006-11-30T06:32:39","guid":{"rendered":"https:\/\/www.17047165566933.sritis.lt\/index.php\/2006\/11\/30\/kovai-su-kruties-veziu-europos-sajungos-lesos\/"},"modified":"2006-11-30T08:32:39","modified_gmt":"2006-11-30T06:32:39","slug":"kovai-su-kruties-veziu-europos-sajungos-lesos","status":"publish","type":"post","link":"https:\/\/www.santaka.info\/index.php\/2006\/11\/30\/kovai-su-kruties-veziu-europos-sajungos-lesos\/","title":{"rendered":"Kovai su kr\u016bties v\u0117\u017eiu \u2013 Europos S\u0105jungos l\u0117\u0161os"},"content":{"rendered":"<p><em><\/em><\/p>\n<p>Visame pasaulyje diagnoz\u0117 \u201eJums kr\u016bties v\u0117\u017eys\u201c i\u0161 gydytoj\u0173 l\u016bp\u0173 moterims nuskamba kas tris minutes kasdien. Remiantis statistikos duomenimis, viena i\u0161 a\u0161tuoni\u0173 pasaulio moter\u0173 savo gyvenime gali susirgti kr\u016bties v\u0117\u017eiu. Daugiau nei nuo kr\u016bties v\u0117\u017eio moter\u0173 \u017e\u016bva tik automobili\u0173 avarijose.<br \/>\n<br \/>Kr\u016bties v\u0117\u017eys \u2013 da\u017eniausia tarp moter\u0173 pasitaikanti v\u0117\u017eio forma Europos S\u0105jungoje (ES) ir Lietuvoje. ES kasmet u\u017eregistruojama 275\u00a0000 kr\u016bties v\u0117\u017eio atvej\u0173 ir 88\u00a0000 moter\u0173 mir\u010di\u0173 nuo \u0161ios klastingos ligos. Tai pagrindin\u0117 35\u201359 met\u0173 moter\u0173 mirties prie\u017eastis. Taip pat kasmet nuo kr\u016bties v\u0117\u017eio mir\u0161ta ir beveik 1000 vyr\u0173.<br \/>\n<br \/>Lietuvoje nuo 1990 m. mirtingumas nuo \u0161ios ligos padid\u0117jo 31,9 proc., kasmet ja m\u016bs\u0173 \u0161alyje suserga daugiau nei 1300 moter\u0173, ma\u017edaug pus\u0117 susirgusi\u0173j\u0173 nepasveikusios mir\u0161ta.<br \/>\n<br \/>\u0160ie faktai kelia siaub\u0105. O Europos S\u0105junga, deja, dar toli gra\u017eu nesutelk\u0117 vis\u0173 savo pastang\u0173 kovoti su \u0161ia klastinga liga ir dar nepareng\u0117 efektyvi\u0173 priemoni\u0173 prie\u0161 jos plitim\u0105. Tr\u016bksta tyrim\u0173 apie kr\u016bties v\u0117\u017eio paplitim\u0105, ankstyv\u0105 diagnostik\u0105 ir gydym\u0105, reikia tobulinti standartus ir protokolus, skirtus u\u017etikrinti kr\u016bties v\u0117\u017eio tyrim\u0173 kokyb\u0119, diegti alternatyvas tradicinei mamografijai, pvz., skaitmenin\u0119 mamografij\u0105.<br \/>\n<br \/>ES gair\u0117s d\u0117l kr\u016bties v\u0117\u017eio kol kas n\u0117ra prieinamos vis\u0173 valstybi\u0173 gydytojams ir pacient\u0173 organizacijoms internete. N\u0117ra efektyvi\u0173 program\u0173, reintegruojan\u010di\u0173 \u012f darbo rink\u0105 i\u0161gijusius nuo kr\u016bties v\u0117\u017eio, tr\u016bksta kr\u016bties v\u0117\u017eiu sergan\u010di\u0173 ligoni\u0173 teisi\u0173 darbo vietoje apsaugos sistemos. Akivaizdu, kad ES turi nedelsiant veikti.<br \/>\n<br \/>Lietuvoje onkologin\u0117 pagalba ligoniams smarkiai atsilieka nuo kit\u0173 ES \u0161ali\u0173. Daugumai su kr\u016bties v\u0117\u017eiu kovojan\u010di\u0173 Lietuvos moter\u0173 neprieinamas joms gyvybi\u0161kai svarbus biologin\u0117s terapijos medikamentas herceptinas, kainuojantis apie 100 000 lit\u0173 ir kompensuojamas tik i\u0161imtiniais atvejais.<br \/>\n<br \/>2006 metais Sveikatos apsaugos ministerija skyr\u0117 2,5 mln. lit\u0173 herceptinui \u012fsigyti. \u0160is medikamento kiekis leis gydyti tik 50 moter\u0173 ir taikyti joms tik pus\u0119 reikalingo gydymo kurso. Kitos moterys paliekamos likimo valiai.<br \/>\n<br \/>Tr\u016bksta specialist\u0173 \u2013 onkolog\u0173-mamolog\u0173, taip pat moderni\u0173 mamograf\u0173, kuriais galima diagnozuoti kr\u016bties v\u0117\u017e\u012f ankstyvose stadijose ir s\u0117kmingai j\u012f i\u0161gydyti. Tod\u0117l norint i\u0161sitirti moterims eil\u0117je tenka laukti net 3 m\u0117nesius.<br \/>\n<br \/>Tr\u016bksta ir modernios \u0161vitinimui skirtos aparat\u016bros. O konkursai d\u0117l pirkimo labai \u201es\u0117kmingai\u201c stringa biurokratiniuose koridoriuose. \u017dvelgiant i\u0161 \u0161alies atrodo, kad kalba eina apie dar vieno \u201enesvarbaus\u201c teis\u0117s akto pri\u0117mim\u0105, kuris gali strigti, o ne apie pavoj\u0173 visuomen\u0117s sveikatai.<br \/>\n<br \/>Juk svarbiausia \u2013 gyvybi\u0173 i\u0161saugojimas demografin\u0119 kriz\u0119 i\u0161gyvenan\u010dioje m\u016bs\u0173 visuomen\u0117je. Tod\u0117l b\u016btina nedelsiant inicijuoti onkologijos srities reformavim\u0105. Standartinis vald\u017eios atsakymas: \u201eN\u0117ra l\u0117\u0161\u0173\u201c, nebus priimtinas nei jau sergantiems kr\u016bties v\u0117\u017eiu, nei visiems kitiems, neapsaugotiems nuo rizikos susirgti \u0161ia klastinga liga.<br \/>\n<br \/>Pinig\u0173 tikrai atsirast\u0173 persvars\u010dius valstyb\u0117s prioritetus ir supaprastinus pirkimo proced\u016bras. Dabar sukurta kokybi\u0161ka kr\u016bties v\u0117\u017eini\u0173 susirgim\u0173 prevencijos sistema sveikatos apsaugos institucijoms pad\u0117t\u0173 sutaupyti nema\u017eai l\u0117\u0161\u0173 ateityje, nes b\u016bt\u0173 i\u0161vengta nereikaling\u0173 tyrim\u0173, laiku b\u016bt\u0173 atpa\u017e\u012fstamos ligos u\u017euomazgos, reik\u0117t\u0173 ma\u017eiau brangaus gydymo ir operacij\u0173.<br \/>\n<br \/>Spalio 25 d. Europos Parlamentas pri\u0117m\u0117 Rezoliucij\u0105 d\u0117l kr\u016bties v\u0117\u017eio susirgim\u0173 i\u0161sipl\u0117tusioje Europos S\u0105jungoje.<br \/>\n<br \/>Pabr\u0117\u017edamas spart\u0173 kraujo v\u0117\u017eio plitim\u0105 ir keliam\u0105 gr\u0117sm\u0119 \u017emoni\u0173 gyvyb\u0117ms, Europos Parlamentas skatina ES valstybes nares pasinaudoti Europos socialiniais fondais (kandidat\u0117s nar\u0117s kvie\u010diamos naudotis pasiruo\u0161imo narystei fondais) ir rengti reikaling\u0105 medicinos personal\u0105.<br \/>\n<br \/>Europos regionin\u0117s pl\u0117tros fondai (ERPF) naujose valstyb\u0117se nar\u0117se gali b\u016bti naudojami sveikatos infrastrukt\u016broms kurti, o kartu \u2013 ir mamografijos bei specializuot\u0173 kr\u016bties tyrim\u0173 centrams steigti. B\u016btina aktyviai finansuoti kr\u016bties v\u0117\u017eio susirgim\u0173 prevencijos tyrimus, kraujo test\u0173 tobulinim\u0105.<br \/>\n<br \/>Nustokime dejuoti, kad n\u0117ra l\u0117\u0161\u0173 kovoti su v\u0117\u017eiu, ir pasinaudokime ES parama Lietuvos sveikatos apsaugos infrastrukt\u016brai onkologini\u0173 susirgim\u0173 srityje modernizuoti \u2013 mamografijos tyrimams \u012fgyvendinti, specializuot\u0173 kr\u016bties susirgim\u0173 centrams steigti, specialistams ruo\u0161ti.<\/p>\n<p>Dr. Danut\u0117 BUDREIKAIT\u0116<br \/>\n<br \/>Europos Parlamento Liberal\u0173 ir demokrat\u0173 aljanso u\u017e Europ\u0105 frakcijos nar\u0117<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Visame pasaulyje diagnoz\u0117 \u201eJums kr\u016bties v\u0117\u017eys\u201c i\u0161 gydytoj\u0173 l\u016bp\u0173 moterims nuskamba kas tris minutes kasdien. Remiantis statistikos duomenimis, viena i\u0161 a\u0161tuoni\u0173 pasaulio moter\u0173 savo gyvenime gali susirgti kr\u016bties v\u0117\u017eiu. Daugiau&#8230; <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pmpro_default_level":"","jetpack_post_was_ever_published":false,"_FSMCFIC_featured_image_caption":"NULL \/ NULL","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-101166","post","type-post","status-publish","format-standard","hentry","category-uncategorized","pmpro-has-access"],"featured_image_urls":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","post-thumbnail":"","visualnews_post_thumb":"","woocommerce_thumbnail":"","woocommerce_single":"","woocommerce_gallery_thumbnail":""},"author_info":{"info":["admin"]},"category_info":"<a href=\"https:\/\/www.santaka.info\/index.php\/category\/uncategorized\/\" rel=\"category tag\">Be kategorijos<\/a>","tag_info":"Be kategorijos","comment_count":"0","jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts\/101166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/comments?post=101166"}],"version-history":[{"count":0,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts\/101166\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/media?parent=101166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/categories?post=101166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/tags?post=101166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}